Sign Up for FORCE
Newsletters
FORCE advocates for families facing hereditary cancer in areas such as access to care, research funding, insurance and privacy.
FORCE advocates for families facing hereditary cancer in areas such as access to care, research funding, insurance and privacy.
- Florida Enacts Sweeping Genetic Protection Law
- Medicare Finalizes Genetic Testing Policy
- BRCA Genetic Screening Recommendations Miss the Mark
- Fraud Alert! Genetic test scams are a growing problem.
- New Legislative Effort Could Wipe Out Laws Preventing Gene Patents
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- FORCE Leads the Charge for Medicaid Coverage of Genetic Testing
- FDA Approves New Direct-to-Consumer Genetic Test for 3 BRCA Mutations
- Clarification Includes Survivors in BRCA Screening Guidelines
- Supreme Court Rules Gene Patents Unlawful
- Protections against genetic discrimination vs. pre-existing conditions
- Florida Enacts Sweeping Genetic Protection Law
- Fraud Alert! Genetic test scams are a growing problem.
- Lawsuit Targets Wellness Program Penalties and Invasion of Privacy
- Lawsuit Challenges ACA Preexisting Conditions Protections
- Statement Sets the Record Straight on AHCA and HR 1313
- Genetic Information Nondiscrimination Act (GINA)
- FORCE Fights for Our Community, COVID Relief
- Florida Enacts Sweeping Genetic Protection Law
- BRCA Genetic Screening Recommendations Miss the Mark
- Fraud Alert! Genetic test scams are a growing problem.
- Statement Sets the Record Straight on AHCA and HR 1313
- EARLY Act Brings Young Breast Cancer to Forefront
- Establishment of National HBOC Week and Previvor Day
- Protect Access to Free Annual Screening Mammograms for Women Ages 40-49
- Protections against genetic discrimination vs. pre-existing conditions
- FORCE Fights for Our Community, COVID Relief
- Medicare Finalizes Genetic Testing Policy
- BRCA Genetic Screening Recommendations Miss the Mark
- Mammograms for Women Age 40-49 Preserved Until 2020
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- FORCE Supports Chemotherapy Parity Initiatives
- ACA unconstitutional? What does this mean for preventive care and pre-existing conditions?
- New Federal Regulations and Proposals May Hurt High-Risk Cancer Community
- Lawsuit Challenges ACA Preexisting Conditions Protections
- FORCE Leads the Charge for Medicaid Coverage of Genetic Testing
- Ovarian Cancer Screening for High-Risk Women
- Prostate Cancer Screening Guidelines Fall Short
- Clarification Includes Survivors in BRCA Screening Guidelines
- Statement Sets the Record Straight on AHCA and HR 1313
- Protect Access to Free Annual Screening Mammograms for Women Ages 40-49
- FORCE Fights for Our Community, COVID Relief
- FORCE Weighs in on Breast Implant Safety and Informed Consent
- Mammograms for Women Age 40-49 Preserved Until 2020
- High-Risk Individuals Often Struggle to Get Insurance Coverage of Health Services
- ACA unconstitutional? What does this mean for preventive care and pre-existing conditions?
- Cancer Research Funding Preserved
- Ovarian Cancer Screening for High-Risk Women
- Prostate Cancer Screening Guidelines Fall Short
- FDA Updates Breast Implant Safety Info, Releases Educational Video
- Medicare Finalizes Genetic Testing Policy
- FORCE Weighs in on Breast Implant Safety and Informed Consent
- FORCE Supports Chemotherapy Parity Initiatives
- New Federal Regulations and Proposals May Hurt High-Risk Cancer Community
- Federal "Right to Try" Legislation Passes, Signed by President
- Cancer Research Funding Preserved
Take Action Now
2022 Priorities
Public Policy Initiatives
News Briefs
06/2/2022 - Asked congressional leaders to continue support and to increase funding for the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD).
5/22/2022 - Provided feedback to the Senate HELP Committee urging changes to the VALID Act, which would reform the way lab tests are regulated. This followed a sign-on letter regarding the bill submitted the previous week.
5/11/2022 - Joined 90 orgs in a letter to House leadership urging them to include measures to improve clinical trial diversity in this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.
Sponsored By:
